CompuGroup Medical SE & Co. KGaA

  • Market Cap: Small Cap
  • Industry: Services to the Health Industry
  • ISIN: DE000A288904
EUR
22.66
0.24 (1.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

145.38 k

Shareholding (Jun 2023)

FII

20.26%

Held by 251 FIIs

DII

3.21%

Held by 8 DIIs

Promoter

50.37%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Operating profit has grown by an annual rate 1.32% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Poor long term growth as Operating profit has grown by an annual rate 1.32% of over the last 5 years

 
3

Flat results in Mar 24

4

Risky -

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Services to the Health Industry

stock-summary
Market cap

EUR 1,218 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.95

stock-summary
Return on Equity

5.52%

stock-summary
Price to Book

1.88

Revenue and Profits:
Net Sales:
309 Million
(Quarterly Results - Dec 2024)
Net Profit:
-6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.18%
0%
-0.18%
6 Months
4.42%
0%
4.42%
1 Year
-10.43%
0%
-10.43%
2 Years
-51.6%
0%
-51.6%
3 Years
-46.46%
0%
-46.46%
4 Years
-65.33%
0%
-65.33%
5 Years
-64.84%
0%
-64.84%

CompuGroup Medical SE & Co. KGaA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.22%
EBIT Growth (5y)
1.32%
EBIT to Interest (avg)
10.30
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
0.90
Sales to Capital Employed (avg)
0.80
Tax Ratio
43.28%
Dividend Payout Ratio
7.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.20%
ROE (avg)
15.54%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.16
EV to EBIT
13.92
EV to EBITDA
7.88
EV to Capital Employed
1.61
EV to Sales
1.78
PEG Ratio
0.74
Dividend Yield
3.61%
ROCE (Latest)
11.58%
ROE (Latest)
13.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 64 Schemes (6.69%)

Foreign Institutions

Held by 251 Foreign Institutions (20.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 0.59% vs -6.35% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 61.29% vs -208.39% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "308.70",
          "val2": "306.90",
          "chgp": "0.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.10",
          "val2": "68.00",
          "chgp": "-27.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "15.70",
          "val2": "7.70",
          "chgp": "103.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-44.00",
          "chgp": "99.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.00",
          "val2": "-15.50",
          "chgp": "61.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "63.90%",
          "val2": "102.20%",
          "chgp": "-3.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.84% vs 5.13% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -25.80% vs -36.71% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,154.00",
          "val2": "1,187.70",
          "chgp": "-2.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "201.30",
          "val2": "271.00",
          "chgp": "-25.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "36.30",
          "val2": "28.00",
          "chgp": "29.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-67.30",
          "chgp": "95.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34.80",
          "val2": "46.90",
          "chgp": "-25.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "77.70%",
          "val2": "130.60%",
          "chgp": "-5.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
308.70
306.90
0.59%
Operating Profit (PBDIT) excl Other Income
49.10
68.00
-27.79%
Interest
15.70
7.70
103.90%
Exceptional Items
-0.30
-44.00
99.32%
Consolidate Net Profit
-6.00
-15.50
61.29%
Operating Profit Margin (Excl OI)
63.90%
102.20%
-3.83%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 0.59% vs -6.35% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 61.29% vs -208.39% in Dec 2023

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,154.00
1,187.70
-2.84%
Operating Profit (PBDIT) excl Other Income
201.30
271.00
-25.72%
Interest
36.30
28.00
29.64%
Exceptional Items
-2.80
-67.30
95.84%
Consolidate Net Profit
34.80
46.90
-25.80%
Operating Profit Margin (Excl OI)
77.70%
130.60%
-5.29%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.84% vs 5.13% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -25.80% vs -36.71% in Dec 2023

stock-summaryCompany CV
About CompuGroup Medical SE & Co. KGaA stock-summary
stock-summary
CompuGroup Medical SE & Co. KGaA
Services to the Health Industry
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available